Smith Stan's Form 4 filing
MAIA Biotechnology, Inc. (MAIA) · filed Dec 27, 2022
- Accession no.
- 0001127602-22-028285
- Filed
- Dec 27, 2022
- Trade date
- Dec 22-23, 2022
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $5.83K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Smith StanCIK 0001913199 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 22, 2022 | Common Stock | PPurchaseAcquired | +731 | $3.34 | +$2,441.54 | 508,506 | Indirect | |
| Dec 23, 2022 | Common Stock | PPurchaseAcquired | +981 | $3.45 | +$3,384.45 | 509,487 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.